COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:
Working… Menu

Whole Body Vibration - a New Therapeutic Approach to Improve Muscle Function in CF

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00388466
Recruitment Status : Completed
First Posted : October 16, 2006
Last Update Posted : October 16, 2006
Information provided by:
University of Cologne

Brief Summary:
The purpose of this study is to evaluate the effects of whole body vibration (WBV) on muscle function in adult CF-patients.

Condition or disease Intervention/treatment Phase
Cystic Fibrosis Device: GALILEO Not Applicable

Detailed Description:

Cystic Fibrosis (CF) is the most common chronic hereditary disease in Caucasians. Due to improved therapy and better understanding of the disease, life expectancy has risen to an average of 38 years and is continuing to rise. With the increased life-expectancy it becomes even more important to maintain functional activity as part of quality of life. Mechanical stimulation in form of whole body vibration (WBV) is a new type of exercise currently tested in sports, geriatrics and rehabilitation. It has recently been found to be a safe and efficient method to activate muscular activity via stretch reflexes leading to improvement of muscular performance, body balance and physical functioning.

10 patients of the CF Center Cologne, Germany, took part in the Galileo study. They were provided by the vibrating platform (Galileo 2000)for whole body vibration training at home. The patients were standing in an upright position receiving vertical vibration of frequencies between 20-25 Hz. This vibration exercise evokes muscle contractions via stretch reflexes improving muscular activity. The training schedule consisted of three 3-minute sessions twice a day 5 days per week for 3 months.

Every 4 weeks the patients were seen for assessment of muscle function to evaluate the effects of this new intervention.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 10 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Cystic Fibrosis: Improvement of Muscle Force and Function by Whole Body Vibration Exercise
Study Start Date : June 2005
Study Completion Date : August 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cystic Fibrosis

Primary Outcome Measures :
  1. muscle force at the beginning of the study and after 3 months
  2. muscle power at the beginning of the study and after 3 months

Secondary Outcome Measures :
  1. pulmonary function testing at the beginning of the study and after 3 months

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • clinical diagnosis of Cystic Fibrosis
  • age older than 18 years

Exclusion Criteria:

  • hypersplenic syndrome
  • acute arthritis or osteomyelitis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00388466

Layout table for location information
CF Center Cologne, University Children's Hospital
Cologne, Germany, 50924
Sponsors and Collaborators
University of Cologne
Layout table for investigator information
Study Chair: Eckhard Schoenau, Prof. University Children´s Hospital Cologne, Germany
Layout table for additonal information Identifier: NCT00388466    
Other Study ID Numbers: 05-005
First Posted: October 16, 2006    Key Record Dates
Last Update Posted: October 16, 2006
Last Verified: October 2006
Keywords provided by University of Cologne:
whole body vibration
muscle function
cystic fibrosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Cystic Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases